HIRSCHMAN ORIN 13D and 13G filings for Cyclo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2021-02-11 6:25 pm Sale |
2021-02-09 | 13G | Cyclo Therapeutics, Inc. CYTH |
HIRSCHMAN ORIN | 209,383 4.990% |
-208,617![]() (-49.91%) |
Filing |
2020-12-17 08:11 am Purchase |
2020-12-08 | 13G | Cyclo Therapeutics, Inc. CYTH |
HIRSCHMAN ORIN | 418,000 9.900% |
418,000![]() (New Position) |
Filing |